Thrombospondin	0	14	B-Gene_or_gene_product
-	14	15	I-Gene_or_gene_product
2	15	16	I-Gene_or_gene_product
plays	17	22	O
a	23	24	O
protective	25	35	O
role	36	40	O
in	41	43	O
multistep	44	53	O
carcinogenesis	54	68	O
:	68	69	O
a	70	71	O
novel	72	77	O
host	78	82	O
anti	83	87	O
-	87	88	O
tumor	88	93	B-Pathological_formation
defense	94	101	O
mechanism	102	111	O
.	111	112	O

The	114	117	O
angiogenic	118	128	O
switch	129	135	O
during	136	142	O
tumorigenesis	143	156	O
is	157	159	O
thought	160	167	O
to	168	170	O
be	171	173	O
induced	174	181	O
by	182	184	O
a	185	186	O
change	187	193	O
in	194	196	O
the	197	200	O
balance	201	208	O
of	209	211	O
pro	212	215	O
-	215	216	O
angiogenic	217	227	O
and	228	231	O
anti	232	236	O
-	236	237	O
angiogenic	237	247	O
factors	248	255	O
.	255	256	O

To	257	259	O
elucidate	260	269	O
the	270	273	O
biological	274	284	O
role	285	289	O
of	290	292	O
the	293	296	O
endogenous	297	307	O
angiogenesis	308	320	O
inhibitor	321	330	O
thrombospondin	331	345	B-Gene_or_gene_product
-	345	346	I-Gene_or_gene_product
2	346	347	I-Gene_or_gene_product
(	348	349	O
TSP	349	352	B-Gene_or_gene_product
-	352	353	I-Gene_or_gene_product
2	353	354	I-Gene_or_gene_product
)	354	355	O
during	356	362	O
multistep	363	372	O
carcinogenesis	373	387	O
,	387	388	O
we	389	391	O
subjected	392	401	O
TSP	402	405	B-Gene_or_gene_product
-	405	406	I-Gene_or_gene_product
2	406	407	I-Gene_or_gene_product
-	407	408	O
deficient	408	417	O
and	418	421	O
wild	422	426	O
-	426	427	O
type	427	431	O
mice	432	436	B-Organism
to	437	439	O
a	440	441	O
chemical	442	450	O
skin	451	455	B-Organ
carcinogenesis	456	470	O
regimen	471	478	O
.	478	479	O

Surprisingly	480	492	O
,	492	493	O
TSP	494	497	B-Gene_or_gene_product
-	497	498	I-Gene_or_gene_product
2	498	499	I-Gene_or_gene_product
expression	500	510	O
was	511	514	O
strongly	515	523	O
upregulated	524	535	O
in	536	538	O
the	539	542	O
mesenchymal	543	554	B-Tissue
stroma	555	561	I-Tissue
of	562	564	O
wild	565	569	O
-	569	570	O
type	570	574	O
mice	575	579	B-Organism
throughout	580	590	O
the	591	594	O
consecutive	595	606	O
stages	607	613	O
of	614	616	O
tumorigenesis	617	630	O
whereas	631	638	O
the	639	642	O
angiogenesis	643	655	O
factor	656	662	O
,	662	663	O
vascular	664	672	B-Gene_or_gene_product
endothelial	673	684	I-Gene_or_gene_product
growth	685	691	I-Gene_or_gene_product
factor	692	698	I-Gene_or_gene_product
,	698	699	O
was	700	703	O
induced	704	711	O
predominantly	712	725	O
in	726	728	O
tumor	729	734	B-Cell
cells	735	740	I-Cell
.	740	741	O

TSP	742	745	B-Gene_or_gene_product
-	745	746	I-Gene_or_gene_product
2	746	747	I-Gene_or_gene_product
deficiency	748	758	O
dramatically	759	771	O
enhanced	772	780	O
susceptibility	781	795	O
to	796	798	O
skin	799	803	B-Organ
carcinogenesis	804	818	O
and	819	822	O
resulted	823	831	O
in	832	834	O
accelerated	835	846	O
and	847	850	O
increased	851	860	O
tumor	861	866	B-Pathological_formation
formation	867	876	O
.	876	877	O

The	878	881	O
angiogenic	882	892	O
switch	893	899	O
occurred	900	908	O
in	909	911	O
early	912	917	O
stages	918	924	O
of	925	927	O
pre	928	931	O
-	931	932	O
malignant	932	941	O
tumor	942	947	B-Pathological_formation
formation	948	957	O
,	957	958	O
and	959	962	O
tumor	963	968	B-Pathological_formation
angiogenesis	969	981	O
was	982	985	O
significantly	986	999	O
enhanced	1000	1008	O
in	1009	1011	O
TSP	1012	1015	B-Gene_or_gene_product
-	1015	1016	I-Gene_or_gene_product
2	1016	1017	I-Gene_or_gene_product
-	1017	1018	O
deficient	1018	1027	O
mice	1028	1032	B-Organism
.	1032	1033	O

While	1034	1039	O
TSP	1040	1043	B-Gene_or_gene_product
-	1043	1044	I-Gene_or_gene_product
2	1044	1045	I-Gene_or_gene_product
deficiency	1046	1056	O
did	1057	1060	O
not	1061	1064	O
affect	1065	1071	O
tumor	1072	1077	B-Pathological_formation
differentiation	1078	1093	O
or	1094	1096	O
proliferation	1097	1110	O
,	1110	1111	O
tumor	1112	1117	B-Cell
cell	1118	1122	I-Cell
apoptosis	1123	1132	O
was	1133	1136	O
significantly	1137	1150	O
reduced	1151	1158	O
.	1158	1159	O

These	1160	1165	O
results	1166	1173	O
reveal	1174	1180	O
upregulation	1181	1193	O
of	1194	1196	O
an	1197	1199	O
endogenous	1200	1210	O
angiogenesis	1211	1223	O
inhibitor	1224	1233	O
during	1234	1240	O
multi	1241	1246	O
step	1247	1251	O
tumorigenesis	1252	1265	O
and	1266	1269	O
identify	1270	1278	O
enhanced	1279	1287	O
stromal	1288	1295	O
TSP	1296	1299	B-Gene_or_gene_product
-	1299	1300	I-Gene_or_gene_product
2	1300	1301	I-Gene_or_gene_product
expression	1302	1312	O
as	1313	1315	O
a	1316	1317	O
novel	1318	1323	O
host	1324	1328	O
anti	1329	1333	O
-	1333	1334	O
tumor	1334	1339	B-Pathological_formation
defense	1340	1347	O
mechanism	1348	1357	O
.	1357	1358	O

